CD Targeted Bispecific Antibody Market is expected at an 14.5% CAGR during the forecast period for 2025-2034. InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis,...
Peptide Cancer Vaccine Market Size is valued at USD 1.6 Bn in 2024 and is predicted to reach USD 13.9 Bn by the year 2034 at a 24.5% CAGR during the forecast period for 2025-2034. Peptide cancer vaccines utilize tumour-derived peptides that stimul...
Crude Heparin Market Size Was valued at USD 9.1 Bn in 2024 and is predicted to reach USD 17.8 Bn by 2034 at a 7.2% CAGR during the forecast period for 2025-2034. Crude heparin is an unprocessed, unrefined form of the anticoagulant medication hepar...
RNAi Drug Delivery Market Size is valued at USD 108.8 Bn in 2024 and is predicted to reach USD 559.6 Bn by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034. Drug delivery using RNA interference (RNAi) holds promise for the cr...
Global Aseptic Fill Finish Market Size is valued at USD 6.0 Billion in 2024 and is predicted to reach USD 16.9 Billion by the year 2034 at a 11.0% CAGR during the forecast period for 2025-2034. Aseptic processing is an important step in drug ...
Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the tr...
Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through...
Trastuzumab Biosimilar Market is expected to grow at a 25.0 % CAGR during the forecast period for 2025-2034. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). HER2...
Oncolytic Virus Therapy Market is estimated to grow at a 24.5% CAGR during the forecast period for 2025-2034. In recent decades, the healthcare burden of Cancer increasing rapidly with an increasing incidence rate. The massive investment in resear...
The Psoriasis Biosimilars Market Size is valued at USD 8.5 billion in 2023 and is predicted to reach USD 19.3 billion by the year 2031 at a 10.9% CAGR during the forecast period for 2024-2031. Biosimilars for psoriasis are economically viable subs...